Equities

Iaso Private General Obstetric Gynecological & Paediatrics Clinic Diagnostic The

Iaso Private General Obstetric Gynecological & Paediatrics Clinic Diagnostic The

Actions
  • Price (EUR)1.13
  • Today's Change-0.004 / -0.35%
  • Shares traded0.00
  • 1 Year change28.18%
  • Beta--
Data delayed at least 15 minutes, as of Dec 06 2019.
More ▼

Profile data is unavailable for this security.

About the company

Iaso Private General Obstetric Gynecological & Paediatrics Clinic Diagnostic Therapeutic & Research Center SA (IASO) is a Greece-based company engaged in the provision of medical services, which includes a range of diagnostic, therapeutic and research services. It operates IASO Maternity Hospital (I.M.H), IASO Children’s Hospital (I.C.H) and IASO General Hospital (I.G.H). I.M.H has a capacity of 350 beds, over 15,000 deliveries, 28,300 inpatients and over 917,000 diagnostic examinations annually, as well as it operates a number of units such as Neonatal Intensive Care, Breast Center and Cardiotocography unit. I.C.H provides medical care, treatment and nursing services, with a total capacity of 65 beds, 15,954 inpatients and over 476,000 diagnostic examinations annually. I.G.H has 222 beds and a number of units such as Cardio-Surgical and Intensive Care unit. Finally, IASO Thessalias Hospital is a General and Obstetrics Clinic which has a total capacity of 169 beds.

  • Revenue in EUR (TTM)93.08m
  • Net income in EUR6.49m
  • Incorporated--
  • Employees1.38k
  • Location
    Iaso Private General Obstetric Gynecological & Paediatrics Clinic Diagnostic The37-39, Kifissias Avenue, MaroussiATHINA 151 23GreeceGRC
  • Phone+30 2 106184000
  • Fax+30 2 106184158
  • Websitehttps://www.iaso.gr
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.